Insulet (PODD) – Research Analysts' Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Insulet (NASDAQ: PODD): 5/13/2024 – Insulet had its price target lowered by analysts at Barclays PLC from $213.00 to $200.00. They now have an “equal weight” rating on the stock. 5/10/2024 – Insulet had its price target lowered by analysts at Raymond […]

Related Keywords

Shacey Petrovic ,Raymond James ,Aquila Investment Management ,Jefferies Financial Group Inc ,Wolfe Research ,Barclays Plc ,Nasdaq ,Asset Management One Co ,Canaccord Genuity Group Inc ,Insulet Co ,Insulet Corporation ,Qube Research Technologies Ltd ,News Ratings For Insulet Co Daily ,Canaccord Genuity Group ,Jefferies Financial Group ,Get Free Report ,Director Shacey Petrovic ,Technologies Ltd ,Management One ,Insulin Delivery System ,Personal Diabetes Manager ,Insulet Co Daily ,